A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

394

Participants

Timeline

Start Date

July 7, 2021

Primary Completion Date

April 4, 2023

Study Completion Date

December 5, 2024

Conditions
Hypertension
Interventions
DRUG

Placebo

Placebo administered by SC injection

DRUG

ALN-AGT01

ALN-AGT01 administered by SC injection

Trial Locations (75)

10036

Clinical Trial Site, New York

10456

Clinical Trial Site, The Bronx

20011

Clinical Trial Site, Washington D.C.

21229

Clinical Trial Site, Baltimore

22015

Clinical Trial Site, Burke

27408

Clinical Trial Site, Greensboro

27410

Clinical Trial Site, Greensboro

29607

Clinical Trial Site, Greenville

30101

Clinical Trial Site, Acworth

30214

Clinical Trial Site, Fayetteville

31210

Clinical Trial Site, Macon

31904

Clinical Trial Site, Columbus

32003

Clinical Trial Site, Fleming Island

32204

Clinical Trial Site, Jacksonville

32216

Clinical Trial Site, Jacksonville

32256

Clinical Trial Site, Jacksonville

32801

Clinical Trial Site, Orlando

33021

Clinical Trial Site, Hollywood

33024

Clinical Trial Site, Hollywood

33126

Clinical Trial Site, Miami

33134

Clinical Trial Site, Coral Gables

33135

Clinical Trial Site, Miami

33756

Clinical Trial Site, Clearwater

34102

Clinical Trial Site, Naples

34452

Clinical Trial Site, Inverness

35209

Clinical Trial Site, Birmingham

38119

Clinical Trial Site, Memphis

39209

Clinical Trial Site, Jackson

46383

Clinical Trial Site, Valparaiso

50266

Clinical Trial Site, West Des Moines

61822

Clinical Trial Site, Champaign

65109

Clinical Trial Site, Jefferson City

70124

Clinical Trial Site, New Orleans

70601

Clinical Trial Site, Lake Charles

70769

Clinical Trial Site, Prairieville

76401

Clinical Trial Site, Stephenville

76708

Clinical Trial Site, Waco

77074

Clinical Trial Site, Houston

77081

Clinical Trial Site, Houston

77355

Clinical Trial Site, Magnolia

77375

Clinical Trial Site, Tomball

77584

Clinical Trial Site, Pearland

78229

Clinical Trial Site, San Antonio

78613

Clinical Trial Site, Cedar Park

85281

Clinical Trial Site, Tempe

85282

Clinical Trial Site, Tempe

89119

Clinical Trial Site, Las Vegas

90057

Clinical Trial Site, Los Angeles

90211

Clinical Trial Site, Beverly Hills

90280

Clinical Trial Site, South Gate

91942

Clinical Trial Site, La Mesa

92083

Clinical Trial Site, Vista

92103

Clinical Trial Site, San Diego

97504

Clinical Trial Site, Medford

Unknown

Clinical Trial Site, Red Deer

Clinical Trial Site, New Minas

Clinical Trial Site, Brampton

Clinical Trial Site, Toronto

Clinical Trial Site, Chicoutimi

Clinical Trial Site, Mirabel

Clinical Trial Site, Montreal

Clinical Trial Site, Québec

Clinical Trial Site, Trois-Rivières

Clinical Trial Site, Victoriaville

Clinical Trial Site, San Juan

Clinical Trial Site, Ivano-Frankivsk

Clinical Trial Site, Kharkiv

Clinical Trial Site, Odesa

Clinical Trial Site, Uzhhorod

Clinical Trial Site, Glasgow

Clinical Trial Site, Hexham

Clinical Trial Site, London

Clinical Trial Site, Manchester

00961

Clinical Trial Site, Bayamón

00716

Clinical Trial Site, Ponce

Sponsors
All Listed Sponsors
lead

Alnylam Pharmaceuticals

INDUSTRY